'Free Thinkers for Measles Elimination' meetingArchived
ECDC convened a meeting of public health experts and successful professionals with experience in management, marketing, campaigning, behaviour change and other professional areas. The purpose of the event was to generate new ideas for promoting measles vaccination in Europe.
ECDC and WHO Europe release “MESSAGE” - a tool to assess progress towards measles and rubella eliminationArchived
ECDC and WHO Europe jointly release “MESSAGE - MEaSles and rubella Self Assessment GEnerating tool” for public health experts, to facilitate assessment of the progress made towards measles and rubella elimination.
ECDC to coordinate EUVAC.NET, the European surveillance network for numerous vaccine-preventable diseasesArchived
Starting 15 September 2011, ECDC will be coordinating the former EUVAC.NET network. It is a surveillance network covering measles, mumps, rubella, congenital rubella, pertussis and varicella EU Member States and three countries of the European Economic Area. Data will be hosted by the European Surveillance System (TESSy) at ECDC.
ECDC editorial emphasises doctors’ decisive role in helping eliminate measles, rubella in EUArchived
In an editorial in the scientific journal Eurosurveillance, ECDC noted that, based on numerous studies, paediatricians, family practitioners and nurses form the backbone of each national immunisation programme in the EU.
Rubella revisited: Where are we on the road to disease elimination in Central Europe?Archived
Elimination of rubella and prevention of congenital rubella infection in Europe has been a high priority for the WHO European Regional Office over the past decade. In 2010 the WHO regional committee for Europe renewed its commitment to the elimination of rubella and prevention of CRS with a new target of 2015. For Central Europe to reach the target of rubella elimination and prevention of CRS by 2015, very high vaccine coverage levels need to be maintained and catch-up campaigns continued to address susceptible groups, in particular women of child-bearing age.
Seroprevalence of Measles-, Mumps- and Rubella-Specific IgG Antibodies in German Children and Adolescents and Predictors for SeronegativityArchived
This large population based sero-epidemiological study describes MMR seroprevalence as a whole and calculates independent predictors for seronegativity for measles, mumps and rubella antibodies in Germany.
EU/EEA Member States prepare for next round in annual reporting for verification of measles and rubella elimination
The summary of the the first intercountry meeting, held in Copenhagen on 24-25 March 2015, hosted jointly by WHO/Europe and the European Centre for Disease Prevention and Control (ECDC) to address issues encountered by the national verfication committeees in European Union (EU)/European Economic Area (EEA) Member States.